Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells

World Journal of Gastroenterology

Volumn 9, Issue 9, 2003, Pages 1930-1934

  Sun, Li ^a   Wang, Xu ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALLICIN; TELOMERASE; ZIDOVUDINE;

APOPTOSIS; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METAPHASE; MICROSCOPY; MITOSIS INHIBITION; MORPHOLOGY; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 0141829813     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i9.1930     Document Type: Article

References (42)

1. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015
2. Harley CB. Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-282
3. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995; 87: 884-894
4. Neidle S, Kelland LR. Telomerase as an anti-cancer target: Current status and future prospects. Anticancer Drug Des 1999; 14: 341-347
5. Zhou HP, Wang X, Zhang NZ. Early apoptosis in intestinal and diffuse gastric carcinomas. World J Gastroenterol 2000; 6: 898-901
6. Guo T, Wang X, Wang XY, Wang W, Liu Y, Zhang P, Shi YX, Zhang ZM, Sun QS, Xue T, Liu ZF, Zhu SY, Mao XF. The value of detecting telomerase activity on early diagnosis of lung cancer. Zhongguo Feiai Zazhi 2001; 4: 37-40.
7. Peng MQ, Wang X, Zhu SY, Luo T, Gu T, Yan YL, Liu H. The value of CT scan and detection of telomerase activity in biopsy specimens for early diagnosis of lung carcinoma. Linchuang Fangshe Xue Zazhi 2002; 21: 1-4.
8. Wang XB, Wang X, Zhang NZ. Inhibition of somatostatin analog Octreotide on human gastric cancer cell MKN-45 growth in vitro. Shijie Huaren Xiaohua Zazhi 2002; 10: 40-42
9. Li Y, Lu YY. Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells. World J Gastroenterol 2002; 8: 213-216
10. Li Y, Yang L, Cui JT, Li WM, Guo RF, Lu YY. Construction of cDNA representational difference analysis based on two cDNA libraries and identification of garlic inducible expression genes in human gastric cancer cells. World J Gastroenterol 2002; 8: 208-212
11. Li X, Xie J, Li W. Garlic oil induces differentiation and apoptosis of human gastric cancer cell line. Zhonghua Zhongliu Zazhi 1998; 20: 325-327
12. Arivazhagan S, Nagini S, Santhiya ST, Ramesh A. Protection of N-methyl-N′-nitro-N-nitrosoguanidine-induced in vivo clastogenicity by aqueous garlic extract. Asia Pac J Clin Nutr 2001; 10: 238-241
13. Takezaki T, Gao CM, Wu JZ, Ding JH, Liu YT, Zhang Y, Li SP, Su P, Liu TK, Tajima K. Dietary protective and risk factors for esophageal and stomach cancers in a low-epidemic area for stomach cancer in Jiangsu Province, China: Comparison with those in a high-epidemic area. Jpn J Cancer Res 2001; 92: 1157-1165
14. Tang F, Zhou J, Gu L. In vivo and in vitro effects of selenium-enriched garlic on growth of human gastric carcinoma cells. Zhonghua Zhongliu Zazhi 2001; 23: 461-464
15. Kimsh SH, Kaminker P, Campisi J. Telomeres, aging and cancer: In search of a happy ending. Oncogene 2002; 21: 503-511
16. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460
17. Huffman KE, Levene SD, Tesmer VM, Shay JW, Wright WE. Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang. J Biol Chem 2000; 275: 19719-19722
18. De Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci U S A 1994; 91: 2882-2885
19. Harley CB. Telomerase is not an oncogene. Oncogene 2002; 21: 494-502
20. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002; 21: 564-579
21. Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ, Kim NK. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 1999; 86: 559-565
22. Corey DR. Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 2002; 21: 631-637
23. Elayadi AN, Demieville A, Wancewicz EV, Monia BP, Corey DR. Inhibition of telomerase by 2′-O-(2-methoxyethyl) RNA oligomers: Effect of length, phosphorothioate substitution and time inside cells. Nucleic Acids Res 2001; 29: 1683-1689
24. Tamura Y, Tao M, Miyano-Kurosaki N, Takai K, Takaku H. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells. Antisense Nucleic Acid Drug Dev 2000; 10: 87-96
25. Yegorov YE, Akimov SS, Akhmalisheva AK, Semenova IV, Smirnova YB, Kraevsky AA, Zelenin AV. Blockade of telomerase function in various cells. Anticancer Drug Des 1999; 14: 305-316
26. Yokoyama Y, Takahashi Y, Shinohara A, Wan X, Takahashi S, Niwa K, Tamaya T. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Biochem Biophys Res Commun 2000; 273: 316-321
27. Herbert BS, Pongracz K, Shay JW, Gryaznov SM, Shea-Herbert B. Oligonucleotide N3′- - >P5′ phosphoramidates as efficient telomerase inhibitors. Oncogene 2002; 21: 638-642
28. Melana SM, Holland JF, Pogo BG. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin Cancer Res 1998; 4: 693-696
29. Tejera AM, Alonso DF, Gomez DE, Olivero OA. Chronic in vitro exposure to 3′-azido-2′, 3′-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells. Breast Cancer Res Treat 2001; 65: 93-99
30. Komata T, Kanzawa T, Kondo Y, Kondo S. Telomerase as a therapeutic target for malignant gliomas. Oncogene 2002; 21: 656-663
31. Mohamadi A, Jarrell ST, Shi SJ, Andrawis NS, Myers A, Clouatre D, Preuss HG. Effects of wild versus cultivated garlic on blood pressure and other parameters in hypertensive rats. Heart Dis 2000; 2: 3-9
32. Neil HA, Silagy CA, Lancaster T, Hodgeman J, Vos K, Moore JW, Jones L, Cahill J, Fowler GH. Garlic powder in the treatment of moderate hyperlipidaemia: A controlled trial and meta-analysis. J R Coll Physicians Lond 1996; 30: 329-334
33. Liao F, Jiao L. Ligustrazine, allicin and shear-induced platelet aggregation. Clin Hemorheol Microcirc 2000; 22: 167-168
34. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1999; 1: 125-129
35. Hackett JA, Greider CW. Balancing instability: Dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 2002; 21: 619-626
36. Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997; 272: 14183-14187
37. Fan Y, Lin GJ, Qian LP, Xu ZD, Li H. Effects of β-elemene on both telomerase activity and expression of Bcl-2 gene of gastric cancer SGC-7901 cell. Shanghai Yixue 2001; 24: 490-492
38. Johnson VL, Cooper IR, Jenkins JR, Chow SC. Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells. Exp Cell Res 1999; 251: 175-184
39. Li Y, Liu JH, Zhao Q, Fan LF, Yu YM, Wang LL, Zhao XF, Zhang TD, Zhang TP, Ma TX, Liu PY. The study of allicin inducing BGC-823 human gastric adenocarcinoma cells apoptosis. Zhongguo Zhongxi Yi Jiehe Waike Zazhi 2001; 7: 307-310
40. Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? Oncogene 2002; 21: 688-697
41. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996; 16: 2932-2939
42. Holt SE, Aisner DL, Shay JW, Wright WE. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci U S A 1997; 94: 10687-10692